Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients-Reference-Cited by-同舟云学术

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

Published:2001-10 Issue:4 Volume:60 Page:1460-1468
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Monier-Faugere Marie-Claude,Geng Zhaopo,Mawad Hanna,Friedler Robert M.,Gao Ping,Cantor Tom L.,Malluche Hartmut H.

Publisher

Elsevier BV

Subject

Nephrology

Reference65 articles.

1. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients;Cohen-Solal;J Clin Endocrinol Metab,1991

2. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia;Quarles;J Clin Endocrinol Metab,1992

3. In vivo studies of parathyroid gland function in secondary hyperparathyroidism;Salusky;Adv Nephrol Necker Hosp,1996

4. Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients;Couttenye;Nephrol Dial Transplant,1996

5. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity;Wang;Am J Kidney Dis,1995

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis;Kidney International Reports;2024-07

2. The Molecular Mechanisms Underlying the Systemic Effects Mediated by Parathormone in the Context of Chronic Kidney Disease;Current Issues in Molecular Biology;2024-04-25

3. Bone Turnover Markers: Basic Biology to Clinical Applications;Endocrine Reviews;2022-12-13

4. Treatment of bone loss in CKD5D: Better survival in patients with non-high bone turnover;Clinical Nephrology;2022-11-01

5. Management of osteoporosis in patients with chronic kidney disease;Osteoporosis International;2022-06-24